Innate immune processes in lupus erythematosus

被引:27
作者
Aringer, Martin [1 ]
Guenther, Claudia [2 ]
Lee-Kirsch, Min Ae [3 ]
机构
[1] Tech Univ Dresden, Div Rheumatol, Dept Med 3, Univ Clin Ctr Carl Gustav Carus, D-01307 Dresden, Germany
[2] Tech Univ Dresden, Dept Dermatol, Univ Clin Ctr Carl Gustav Carus, D-01307 Dresden, Germany
[3] Tech Univ Dresden, Div Mol Genet, Dept Pediat, Univ Clin Ctr Carl Gustav Carus, D-01307 Dresden, Germany
关键词
Lupus; Cytokines; TREX1; RNase-H2; SAMHD1; AICARDI-GOUTIERES-SYNDROME; FAMILIAL CHILBLAIN LUPUS; TUMOR-NECROSIS-FACTOR; PLASMACYTOID DENDRITIC CELLS; INTERFERON REGULATORY FACTOR; RESTRICTION FACTOR SAMHD1; TOLL-LIKE RECEPTORS; AUTOIMMUNE-DISEASE; EXONUCLEASE TREX1; RHEUMATOID-ARTHRITIS;
D O I
10.1016/j.clim.2012.11.012
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The innate immune system is involved in the pathogenesis of systemic autoimmune diseases such as systemic lupus erythematosus (SLE) or dermatomyositis. The important role of complement factors of the classical pathway and of Toll like receptors (TLRs) is well established, based on genetic and clinical evidence. Immune complexes activate tumor necrosis factor (THE) in myeloid cells and interferon-alpha (IFN alpha) in plasmacytoid dendritic cells. The latter initiates a positive feedback loop that drives autoimmunity. More recently, mutations in genes encoding intracellular enzymes involved in RNA and DNA handling, which likewise lead to increased IFNa, have been found to cause familial chilblain lupus and to be associated with SLE. Within the immunological disease continuum, these disorders can be placed between autoinflammation and autoimmunity, and we would propose the term autoadjuvant for this group, since the activation of the innate immune system in these diseases appears to lower the threshold for (auto)immune reactions. (C) 2012 Elsevier Inc. All rights reserved.
引用
收藏
页码:216 / 222
页数:7
相关论文
共 86 条
[1]   Complete complement deficiency in a large cohort of familial systemic lupus erythematosus [J].
Aggarwal, R. ;
Sestak, A. L. ;
D'Sousa, A. ;
Dillon, S. P. ;
Namjou, B. ;
Scofield, R. H. .
LUPUS, 2010, 19 (01) :52-57
[2]  
AREND WP, 1985, J IMMUNOL, V134, P3868
[3]   Current state of evidence on 'off-label' therapeutic options for systemic lupus erythematosus, including biological immunosuppressive agents, in Germany, Austria and Switzerland - a consensus report [J].
Aringer, M. ;
Burkhardt, H. ;
Burmester, G. R. ;
Fischer-Betz, R. ;
Fleck, M. ;
Graninger, W. ;
Hiepe, F. ;
Jacobi, A. M. ;
Koetter, I. ;
Lakomek, H. J. ;
Lorenz, H. M. ;
Manger, B. ;
Schett, G. ;
Schmidt, R. E. ;
Schneider, M. ;
Schulze-Koops, H. ;
Smolen, J. S. ;
Specker, C. ;
Stoll, T. ;
Strangfeld, A. ;
Tony, H. P. ;
Villiger, P. M. ;
Voll, R. ;
Witte, T. ;
Doerner, T. .
LUPUS, 2012, 21 (04) :386-401
[4]  
Aringer M, 2011, AUTOIMMUN REV
[5]  
Aringer M, 2008, J RHEUMATOL, V35, P1473
[6]   Effects of short-term infliximab therapy on autoantibodies in systemic lupus erythematosus [J].
Aringer, Martin ;
Steiner, Guenter ;
Graninger, Winfried B. ;
Hoefler, Elisabeth ;
Steiner, Carl W. ;
Smolen, Josef S. .
ARTHRITIS AND RHEUMATISM, 2007, 56 (01) :274-279
[7]   Adverse events and efficacy of TNF-α blockade with infliximab in patients with systemic lupus erythematosus: long-term follow-up of 13 patients [J].
Aringer, Martin ;
Houssiau, Frederic ;
Gordon, Caroline ;
Graninger, Winfried B. ;
Voll, Reinhard E. ;
Rath, Eva ;
Steiner, Guenter ;
Smole, Josef S. .
RHEUMATOLOGY, 2009, 48 (11) :1451-1454
[8]   Interferon-α Abrogates Tolerance Induction by Human Tolerogenic Dendritic Cells [J].
Bacher, Nicole ;
Graulich, Edith ;
Jonuleit, Helmut ;
Grabbe, Stephan ;
Steinbrink, Kerstin .
PLOS ONE, 2011, 6 (07)
[9]   An interferon signature in the peripheral blood of dermatomyositis patients is associated with disease activity [J].
Baechler, Emily C. ;
Bauer, Jason W. ;
Slattery, Catherine A. ;
Ortmann, Ward A. ;
Espe, Karl J. ;
Novitzke, Jill ;
Ytterberg, Steven R. ;
Gregersen, Peter K. ;
Behrens, Timothy W. ;
Reed, Ann M. .
MOLECULAR MEDICINE, 2007, 13 (1-2) :59-68
[10]  
Baumann I, 2002, ARTHRITIS RHEUM-US, V46, P191, DOI 10.1002/1529-0131(200201)46:1<191::AID-ART10027>3.0.CO